Capitalization – Talk Bio

Eli Lilly Becomes First Drugmaker to Reach $1 Trillion Valuation

3 weeks ago talkbio0Tagged Capitalization, Drug Industry, eli lilly, Glucagon-Like Peptide 1, Market, Mounjaro, valuation, Weight-Loss Agents, Zepbound

Eli Lilly; trillion-dollar valuation; weight-loss drugs; Mounjaro; Zepbound; GLP-1 market; pharmaceutical industry; stock market; market capitalization

Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights

1 month ago talkbio0Tagged Capitalization, clinical-stage biopharma, development aspects, exophthalmos producing substance, financial results, Impaired, Market, net loss, Nkarta, Operating expenses, Q3, research

Nkarta; Q3 2025 financial results; net loss; operating expenses; EPS; research and development; impairment; market capitalization; clinical-stage biopharma; corporate highlights

EU Approves Illumina’s Divestment Plan for Cancer Test Maker Grail

2 years ago talkbio0Tagged cancer diagnostic subsidiary, Capitalization, Clearance, Divestment, EU, European Commission, Illumina

Illumina, Grail, EU clearance, Divestment, European Commission, Cancer diagnostic subsidiary, Capitalization terms